Literature DB >> 21152795

Cutaneous Rosai-Dorfman disease: a case report.

Josie da Costa Eiras1, Antônio Pedro Mendes Schettini, Livia Lima de Lima, Liana Hortência Miranda Tubilla, Rosa Maria Libório de Oliveira.   

Abstract

Rosai-Dorfman disease, otherwise known as sinus histiocytosis with massive lymphadenopathy, is a non-Langerhans cell histiocytosis with a benign course and unknown etiology. It was described in 1969 as a painless cervical lymph node enlargement in association with fever, weight loss and sweating. Extranodal disease has been reported in 43% of cases, with involvement of multiple organs. Purely extranodal Rosai-Dorfman disease has been already reported, including forms restricted to the skin. This paper reports a case of purely cutaneous Rosai-Dorfman disease, which is of interest in view of the rarity of this condition.

Entities:  

Mesh:

Year:  2010        PMID: 21152795     DOI: 10.1590/s0365-05962010000500014

Source DB:  PubMed          Journal:  An Bras Dermatol        ISSN: 0365-0596            Impact factor:   1.896


  4 in total

1.  Rosai-Dorfman disease (RDD) in the paraglottic space: report of a case and review of literature.

Authors:  Yu-Ling Ma; Zhuo-Ping Liang; Sheng-En Xu; Zhi-Hui Yang; Yi Peng; Xiao-Qiang Sun; Gang Qin
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

2.  Cutaneous Rosai-Dorfman Disease presenting as a flank swelling.

Authors:  Saleh M AlSalamah; Muhammad Abdullah; Reem Abdullah AlSalamah; Abdul Rehman Abdullah Al Hadlaq; EbtehalSulaiman Al Mogbel; Ghadah Mohammed Al Yahya
Journal:  Int J Health Sci (Qassim)       Date:  2014-10

Review 3.  Intracranial Rosai-Dorfman disease mimicking multiple meningiomas in a child: a case report and review of the literature.

Authors:  Yongji Tian; Junmei Wang; Jin zhao Ge; Zhenyu Ma; Ming Ge
Journal:  Childs Nerv Syst       Date:  2014-09-03       Impact factor: 1.475

4.  Case for diagnosis. Cutaneous Rosai-Dorfman disease.

Authors:  Han Ma; Huaiqiu Huang; Meirong Li; Wei Lai; Chun Lu
Journal:  An Bras Dermatol       Date:  2014 Jan-Feb       Impact factor: 1.896

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.